It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2005.
2005 | Chennai, Tamil Nadu, India | ActiveHextar Pharmaceuticalss Private Limited, a active private limited company, was established on 17 March 2005 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232TN2005PTC055692. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.44 M.
It upholds a compliant status. Its leadership includes Anbazhagan (Managing Director), Kannan (Director). Past directors included Raja Subramanian Ganesan, Rajan Balakrishnan Venkatachalapathy. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.54, First Floor First Main Road, Nanganallur, Chennai, Tamil Nadu, 600061.
U24232TN2005PTC055692
055692
17 March 2005
₹1.00 Cr
₹9.44 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Hextar Pharmaceuticalss Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anbazhagan | Managing Director | 17 Mar 2005 | Current |
| Kannan | Director | 17 Mar 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Feb 2017 | Past |
| Pramod Abcsdd | Director | 06 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hextar Pharmaceuticalss Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 59.07% decrease. The company also saw a substantial fall in profitability, with a 292% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Hextar Pharmaceuticalss had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2007 | State Bank Of India | ₹0.50 M | Open |
| 14 Dec 2007 | State Bank Of India | ₹0.50 M | Open |
| 14 Dec 2007 | State Bank Of India | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hextar Pharmaceuticalss, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hextar Pharmaceuticalss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hextar Pharmaceuticalss's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hextar Pharmaceuticalss Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Hextar Pharmaceuticalss Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 0.05 Cr with Charge ID 10078187 was registered on 14 Dec 2007. was documented.
The activity A charge with State Bank Of India amounted to Rs. 0.05 Cr with Charge ID 10078863 was registered on 14 Dec 2007. was completed.
The activity A charge with State Bank Of India amounted to Rs. 0.05 Cr with Charge ID 10078193 was registered on 14 Dec 2007. was completed.
Anbazhagan was appointed as a Managing Director was appointed as a Managing Director on 17 Mar 2005 & has been associated with this company since 20 years 8 months . was recorded as a recent event.
The CIN of Hextar Pharmaceuticalss Private Limited is U24232TN2005PTC055692.
Hextar Pharmaceuticalss Private Limited is headquartered at No.54, First Floor First Main Road, Nanganallur, Chennai, Tamil Nadu, 600061.
Hextar Pharmaceuticalss Private Limited was incorporated on 17 March 2005.
The current directors of Hextar Pharmaceuticalss Private Limited are
The primary industry of Hextar Pharmaceuticalss Private Limited is Pharma.
Hextar Pharmaceuticalss Private Limited is unlisted.
The authorized capital of Hextar Pharmaceuticalss Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.44 M.
The compliance status of Hextar Pharmaceuticalss Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX